WOBURN, Mass. (September 3, 2024) – Azurity Pharmaceuticals, a pharmaceutical company focused on developing innovative dose forms and formulations of products to serve the needs of overlooked patients, announced today that the U.S. Food and…Original Article
Azurity Pharmaceuticals, Inc. Announces FDA Approval of Nymalize (nimodipine) Oral Solution 30 mg/5 mL Prefilled ENFit® Syringe
